Health care utilization (HCU) by breast cancer (BC) and non-Hodgkin lymphoma (NHL) patients (pts) with chemotherapy (CT) induced febrile neutropenia (FN) in the Netherlands

被引：0
|
作者：
Gelderblom, Hans
Lugtenburg, Pieternella
Nortier, J. W. R.
van Herk-Sukel, Myrthe
Issa, Djamila
Jager, A.
De La Orden, Margarita
van der Werf-Langenberg, Mirte
Houweling, Leanne
De Jong, Floris Aart
机构：
[1] Leiden Univ, Dept Clin Oncol, Med Ctr, Leiden, Netherlands
[2] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands
[3] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands
[5] Erasmus Univ, Dept Med Oncol, Med Ctr, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands
[6] Amgen Int, Ctr Observat Res, Uxbridge, Middx, England
[7] Amgen BV, Med Dept Oncol & Hematol, Breda, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16526
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
    Fust, Kelly
    Li, Xiaoyan
    Maschio, Michael
    Villa, Guillermo
    Parthan, Anju
    Barron, Richard
    Weinstein, Milton C.
    Somers, Luc
    Hoefkens, Caroline
    Lyman, Gary H.
    PHARMACOECONOMICS, 2017, 35 (04) : 425 - 438
  • [42] Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
    Kelly Fust
    Xiaoyan Li
    Michael Maschio
    Guillermo Villa
    Anju Parthan
    Richard Barron
    Milton C. Weinstein
    Luc Somers
    Caroline Hoefkens
    Gary H. Lyman
    PharmacoEconomics, 2017, 35 : 425 - 438
  • [43] A Study of Symptom Burdens Related to Chemotherapy-Induced Anemia in Patients Diagnosed with Breast Cancer, Lung Cancer and Non-Hodgkin Lymphoma
    Chao, Chun
    Family, Leila
    Cannavale, Kimberly
    Pourmoussa, Andrew
    Xu, Lanfang
    Bhakti, Mehta
    Xu, Hairong
    BLOOD, 2016, 128 (22)
  • [44] COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY
    Taylor, D. C.
    Ozer-Deniz, S.
    Hill, G.
    Skornicki, M.
    Danel, A.
    Kunz, E.
    VALUE IN HEALTH, 2010, 13 (07) : A263 - A264
  • [45] COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VS LIPEGFILGRASTIM TO REDUCE THE INCIDENCE OF FEBRILE NEUTROPENIA IN PATIENTS WITH EARLY STAGE BREAST CANCER OR NON-HODGKIN LYMPHOMA
    Fust, K.
    Li, X.
    Maschio, M.
    Villa, G.
    Parthan, A.
    Barron, R.
    Weinstein, M. C.
    Somers, L.
    Hoefkens, C.
    Lyman, G. H.
    VALUE IN HEALTH, 2015, 18 (03) : A204 - A204
  • [46] Trends in Neutropenia-Related Hospitalization in Older Patients with Non-Hodgkin Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy in the United States: 1995-2015
    Li, Shuling
    Liu, Jiannong
    Guo, Haifeng
    Gawade, Prasad L.
    Kim, Christopher
    Bensink, Mark E.
    Chandler, David
    BLOOD, 2018, 132
  • [47] Clinical and financial burden of mental health (MH) conditions in patients (pts) with low-grade non-Hodgkin lymphoma (LG-NHL)
    Yang, Keri
    Esselman, Kaitlyn
    Chuang, Po-Ya
    Furnback, Wesley
    Chanan-Khan, Asher Alban Akmal
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Predicting the risk of chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphoma: Prospective risk model development.
    Dale, DC
    Crawford, J
    Wolff, D
    Agboola, O
    Culakova, E
    Lyman, GH
    BLOOD, 2003, 102 (11) : 305B - 305B
  • [49] HEALTH CARE RESOURCE UTILIZATION (HCRU) IN HOSPITALIZED FEBRILE NEUTROPENIA (FN) PATIENTS TREATED WITH CHEMOTHERAPY FOR SOLID TUMORS (ST) AND HEMATOLOGICAL MALIGNANCIES (HM) IN BULGARIA
    Gercheva, L.
    Goranov, S.
    Raynov, J.
    Mihaylova, Z.
    Mihaylov, G.
    Karanikolov, S.
    Petrova, R.
    VALUE IN HEALTH, 2014, 17 (07) : A656 - A656
  • [50] Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma
    Lyman, GH
    Delgado, DJ
    CANCER, 2003, 98 (11) : 2402 - 2409
12345